Manipal Hospitals Set to Launch Massive $1 Billion IPO in July

Manipal Health Enterprises, the operator behind the renowned Manipal Hospitals chain, is reportedly preparing to launch its highly anticipated initial public offering (IPO) as early as next month. Backed by Temasek Holdings, the healthcare giant is aiming for a massive valuation of approximately $10 billion, signaling a major move in India's healthcare sector.

A Potential Landmark for Indian Equity Markets

If the timing holds, Manipal Hospitals' offering could become India’s first billion-dollar IPO of the year. This comes at a critical juncture for the Indian equity capital markets, which have seen a relatively slow start in 2026 compared to the record-breaking momentum of the previous two years. So far this year, Indian companies have raised approximately $3.6 billion through first-time share sales. A successful listing by Manipal could serve as a significant catalyst, rebuilding investor confidence and providing much-needed momentum to the primary market.

Detailed Structure of the Proposed Offering

Manipal Hospitals has already taken foundational steps toward its public debut by filing its draft prospectus with the market regulator in March. The planned offering is designed as a dual-structured deal consisting of both fresh capital and secondary sales.

According to the filings, the company intends to launch a fresh issue of shares valued at approximately ₹80 billion. Additionally, the offering will include a secondary sale of up to 43.23 million shares, representing roughly a 3.66% stake held by existing investors. While discussions are ongoing and specific details regarding the final size and timing remain subject to change, the scale of the transaction underscores the company's aggressive growth trajectory.

High-Profile Advisors and Strategic Backing

The scale of this IPO has attracted a powerhouse roster of global and domestic financial advisors. Manipal is working with leading institutions, including Kotak Mahindra Capital Co. and Axis Capital Ltd. on the domestic front. On the global stage, the company has enlisted the expertise of Goldman Sachs Group Inc., JPMorgan Chase & Co., Jefferies Financial Group Inc., UBS Securities, and DBS Bank Ltd.

The involvement of these heavyweight advisors, combined with the backing of Temasek Holdings, highlights the institutional interest in Manipal’s business model and its position within the competitive Indian private healthcare landscape. As the company moves toward its July target, all eyes will be on how the market responds to this multi-billion-dollar healthcare play.

Key Takeaways